QA: Oncternal Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001260990_2014_Oncternal_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001260990, Oncternal Therapeutics Inc

  xvar xval
0 AssetsCurrent 15,171,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 112,000
3 remainder_Assets 322,000
4 LiabilitiesCurrent 4,567,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,281,000
9 ResearchAndDevelopmentExpense 32,318,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,488,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,605,000
1 Liabilities 4,567,000
2 Expenses 43,599,000
3 Revenues 0
4 StockholdersEquity 11,038,000
5 NetIncome -42,111,000
6 ComprehensiveNetIncome -42,111,000
7 BaseVar 32,629,500
8 EconomicCapitalRatiobeforeLimitedLiability -1.79
9 EconomicCapitalRatio 1.09

Edgar->Model Mapping

Feature Distribution

Change over Time